Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ASSOCIATION OF COMMUNITY CANCER CENTERS 1 ASSOCIATION OF COMMUNITY CANCER CENTERS Multiple Myeloma Dispensing Models Effective Practices to Improve Care Delivery and the Patient Experience ASSOCIATION OF COMMUNITY CANCER CENTERS ASSOCIATION OF COMMUNITY CANCER CENTERS TABLE OF CONTENTS Overview …
Allen Beck and Rivka Shakow Beck were newlyweds when Allen was diagnosed with myelodysplastic syndrome. Allen and Rivka were thrust into a stressful situation, but financial advocate, Angie Santiago, CRCS, was ready to help.
The VCU Massey Cancer Center incorporated a legal service at their center because more work had to be done to address social determinants of health rooted in legal problems in order to offer comprehensive services that met the full gamut of its patients’ needs.
Measurable residual disease (MRD) has gained traction as a compelling marker for disease status across various hematologic malignancies, including multiple myeloma. Learn how MRD is uniquely suited to help evaluate the depth of treatment response.
With an aging U.S. population and a projected shortage of medical oncologists, oncology pharmacists and the critical support they provide in the management of patient symptoms and comorbidities is more important than ever.
Vanderbilt-Ingram Cancer Center shares details about how it shifted from a push to a pull model of care for patients who present at the emergency department with incidental findings.
Vanderbilt-Ingram Cancer Center shares how auricular acupuncture, a safe, feasible, and cost-effective therapy, that stimulates points on the ear, can reduce the pain and psychological distress experienced by patients with cancer.
Association of Community Cancer Centers This publication is a benefit of membership Association of Community Cancer Centers Vol. 37 | No. 3 | 2022 Treating cancer-related pain with auricular acupuncture | 32 Developing a cannabis clinic for patients with cancer | 26 Implementing a “pull” model for incidental findings | 20 ISSUES ONCOLOGY An APP-Physician Model Improves …
The successful deployment of technology in cancer practices, promises to improve the quality of patient care and the patient experience, while also alleviating excessive burdens on clinicians and staff.
fast facts 8 accc-cancer.org | Month–Month 2000 | OI The Promise of Prescriptive Intelligence The second in the ACCCBuzz series focusing on the 2022-2023 ACCC President’s Theme, Leveraging Technology to Transform Cancer Care Delivery and the Patient Experience, explains how an artificial intelligence platform to that pulls massive amounts of data, including social determinants …
8 accc-cancer.org | Vol. 37, No. 4, 2022 | OI compliance Is My E/M Visit Separately Billable? BY TERI BEDARD, BA, RT(R)(T), CPC • The patient presents with a side effect to their drug therapy, requiring assessment, intervention, or a new prescription. Examples include nausea, pain, fever, diarrhea, or mouth sores. • There is a change in the drug therapy treatment plan that requires …
Kim Woofter, the executive Vice President of Strategic Alliances, AC3, discusses the rewards of incorporating data analytics into the business of oncology, as a tool for improving billing and revenue cycle management and optimizing care.
The ACCC Patient Assistance & Reimbursement Guide is an interactive and fully digital tool, patients, health care providers and members of the multidisciplinary oncology care team can access to help find and apply for financial assistance.
Technology-drive solutions will be essential in the future of cancer care, and providing the information, education and resources health care providers need to implement those solutions is important.
Tennessee Oncology is a physician-led private oncology practice based in Nashville, with 32 clinic locations across the state and one in northern Georgia- offering medical and radiation oncology, imaging, and lab services.
Medicare prior authorization requirements acts as a barrier to patients accessing necessary services and treatments, thus creating a need for reform.
12 accc-cancer.org | Vol. 37, No. 4, 2022 | OI Approved Drugs • On April 18, the U.S. Food and Drug Administration (FDA) approved Alymsys® (bevacizumab-maly) (Brand Institute and mAbxience, brandinstitute.com and mabxience.com)—a biosimilar to Avastin® (bevacizumab). Alymsys’s approved indications include: 1) metastatic colorectal cancer in combination with intravenous fluorouracil-based …
Cancer Care Associates of York, implemented an autonomous APP model of care designed to allow these clinicians to work at the top of their license, facilitate effective physician and APP partnerships, and improve overall patient satisfaction.
ACCC and AstraZeneca were recognized for their joint effort in the Rural Appalachian Lung Cancer Screening Initiative at the Cancer Moonshot: Goals Forum hosted, by the President and First Lady.
A multicentered study based in Ohio measured genetic counseling referrals for patients with cancer.